EGFR and non-small cell lung carcinoma: Importantly, CTRCE emerged as being independently associated with OS in EGFR-mutant NSCLC, and this hazard remained unassociated with preexisting CVD or traditional risk factors, underscoring the necessity for vigilant cardiac monitoring in this patient population.